Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Assets (2020 - 2025)

Historic Current Assets for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $575.8 million.

  • Cellebrite DI's Current Assets rose 145.47% to $575.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $575.8 million, marking a year-over-year increase of 145.47%. This contributed to the annual value of $575.8 million for FY2025, which is 145.47% up from last year.
  • Cellebrite DI's Current Assets amounted to $575.8 million in Q4 2025, which was up 145.47% from $668.4 million recorded in Q3 2025.
  • Over the past 5 years, Cellebrite DI's Current Assets peaked at $668.4 million during Q3 2025, and registered a low of $233.6 million during Q2 2022.
  • Its 5-year average for Current Assets is $403.7 million, with a median of $376.2 million in 2023.
  • In the last 5 years, Cellebrite DI's Current Assets tumbled by 1574.55% in 2021 and then soared by 4613.8% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Current Assets stood at $273.2 million in 2021, then grew by 8.32% to $295.9 million in 2022, then skyrocketed by 42.63% to $422.1 million in 2023, then surged by 34.47% to $567.6 million in 2024, then increased by 1.45% to $575.8 million in 2025.
  • Its last three reported values are $575.8 million in Q4 2025, $668.4 million for Q3 2025, and $606.1 million during Q2 2025.